The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...
In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of ...
The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...
In July 2015, Abbott agreed to buy Tendyne for $225 million upfront and secured an option to acquire Cephea. Abbott CEO ...
At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, ...
CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results